InvestorsHub Logo
Followers 30
Posts 5070
Boards Moderated 0
Alias Born 01/07/2020

Re: None

Thursday, 11/05/2020 10:27:31 AM

Thursday, November 05, 2020 10:27:31 AM

Post# of 426566
cbb@ I think we just might as well 'Drop spending time the arguments On BO - for now (I have supported your views - when I were depressed about development - a number of times - latest here today).
--------------------

As I stated elsewhere a couple of days ago: "BO is simply not going to happen" - and today's statement from JT - also 'Once and for All for now - makes it clear GIA in Europe - is HOW IT'S GOING TO BEE - so fighting against it - is simply waist of time and energy for everybody - end of story.

JT from today on Europe:

“We are excited to be nearing the EMA’s regulatory decision on VASCEPA and are busy preparing for our anticipated commercial launch in Europe, where there is a large and growing opportunity for Amarin to bring this proven effective therapy to the millions of patients at high risk for cardiovascular events. Launching on our own in major markets in Europe allows us to create the greatest value as Amarin would not have to share profits with a partner. Importantly, we can leverage the knowledge and experience gained from the tremendous progress made by our U.S. commercial team.



Interesting that Amarin a actually taking the case to Supreme Court. What I understand (lay person) your case have to be 'special/principal' to have a chance for the highest court - but Law people must think they have a chance - I suppose.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News